Disclosures for "Merits of a Resident-focused Neuro-intensive Care (NICU) Program—An Academic Quaternary-care Hospital Perspective"
-
Dr. Siddiqui has nothing to disclose.
-
Dr. Dasovic has nothing to disclose.
-
An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.